Ameritas Investment Partners’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-84
| Closed | -$3.81K | – | 3140 |
|
|
2024
Q1 | $3.81K | Hold |
84
| – | – | ﹤0.01% | 2982 |
|
|
2023
Q4 | $3.98K | Hold |
84
| – | – | ﹤0.01% | 3006 |
|
|
2023
Q3 | $3.42K | Hold |
84
| – | – | ﹤0.01% | 3031 |
|
|
2023
Q2 | $8.99K | Hold |
84
| – | – | ﹤0.01% | 2941 |
|
|
2023
Q1 | $25.2K | Hold |
84
| – | – | ﹤0.01% | 2366 |
|
|
2022
Q4 | $41.8K | Hold |
84
| – | – | ﹤0.01% | 2185 |
|
|
2022
Q3 | $15K | Hold |
84
| – | – | ﹤0.01% | 2640 |
|
|
2022
Q2 | $17K | Hold |
84
| – | – | ﹤0.01% | 2621 |
|
|
2022
Q1 | $28K | Hold |
84
| – | – | ﹤0.01% | 2398 |
|
|
2021
Q4 | $27K | Buy |
84
+16
| +24% | +$5.14K | ﹤0.01% | 2491 |
|
|
2021
Q3 | $33K | Hold |
68
| – | – | ﹤0.01% | 2410 |
|
|
2021
Q2 | $31K | Hold |
68
| – | – | ﹤0.01% | 2477 |
|
|
2021
Q1 | $47K | Buy |
68
+10
| +17% | +$6.91K | ﹤0.01% | 2117 |
|
|
2020
Q4 | $43K | Hold |
58
| – | – | ﹤0.01% | 2071 |
|
|
2020
Q3 | $41K | Hold |
58
| – | – | ﹤0.01% | 1952 |
|
|
2020
Q2 | $50K | Buy |
58
+25
| +76% | +$21.6K | ﹤0.01% | 1814 |
|
|
2020
Q1 | $12K | Hold |
33
| – | – | ﹤0.01% | 2433 |
|
|
2019
Q4 | $8K | Hold |
33
| – | – | ﹤0.01% | 2797 |
|
|
2019
Q3 | $4K | Hold |
33
| – | – | ﹤0.01% | 2955 |
|
|
2019
Q2 | $6K | Buy |
+33
| New | +$6K | ﹤0.01% | 2912 |
|